{
  "Tool Call": {
    "condition_code": "I50.9",
    "guideline_source": [
      "AHA",
      "ESC",
      "NICE"
    ],
    "patient_age_group": "adult",
    "publication_date_after": "2020-01-01T00:00:00Z",
    "evidence_level_minimum": "B"
  },
  "Return Data": {
    "guidelines_found": 4,
    "guideline_summaries": [
      "AHA/ACC/HFSA 2022 Heart Failure Guidelines: Recommends ACE inhibitors or ARBs as first-line therapy for HFrEF patients with beta-blockers and aldosterone antagonists",
      "ESC 2021 Heart Failure Guidelines: Emphasizes early initiation of guideline-directed medical therapy and device therapy consideration for eligible patients",
      "NICE Heart Failure Guidelines 2018 (Updated 2021): Provides structured approach to diagnosis using natriuretic peptides and echocardiography with lifestyle management recommendations",
      "AHA 2022 Heart Failure Self-Care Guidelines: Evidence-based recommendations for patient education, dietary sodium restriction, and daily weight monitoring"
    ],
    "evidence_levels": [
      "A",
      "A",
      "B",
      "B"
    ]
  }
}